KRD (CARFILZOMIB PLUS LENALIDOMIDE PLUS DEXAMETHASONE) IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA IN CAMPANIA REGION: A ONE-YEAR SURVEY

被引：0

作者：

Palmieri, S. ^{[1
]}

Rocco, S. ^{[1
]}

Migliaccio, I. ^{[1
]}

Cerchione, C. ^{[2
]}

Catalano, L. ^{[2
]}

Ferrara, K. ^{[2
]}

Peluso, I. ^{[2
]}

Monaco, G. ^{[1
]}

Farina, G. ^{[3
]}

Gagliardi, A. ^{[4
]}

Barone, M. ^{[5
]}

Esposito, D. ^{[6
]}

Amico, V. ^{[7
]}

Arcamone, M. ^{[8
]}

Fontana, R. ^{[9
]}

Sica, A. ^{[10
]}

Pane, F. ^{[2
]}

Ferrara, F. ^{[1
]}

机构：

[1] AORN A Cardarelli, Ematol Unita TMO, Naples, Italy

[2] AUOP Federico II, Ematol, Naples, Italy

[3] AORN S Anna & S Sebastiano, UOC Oncoematol, Naples, Italy

[4] ASL Na1 Ctr, Osped Ascalesi, UOC Ematol, Naples, Italy

[5] PO A Tortora, UO Ematol Oncol, Naples, Italy

[6] Osped San Giuseppe Moscati, ASL CE, UOC Ematol, Statte, TA, Italy

[7] AORN G Rummo, DH Ematol, Benevento, Italy

[8] Fdn G Pascale IRCCS, UOSC Ematol Oncol, Naples, Italy

[9] AOU Ruggi dAragona, Ematol, Salerno, Italy

[10] AOU Vanvitelli, Oncol Med & Ematol, Naples, Italy

来源：

HAEMATOLOGICA | 2017年 / 102卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

P188

引用

页码：126 / 126

页数：1

共 50 条

[21] CARFILZOMIB, LENALIDOMIDE AND DEXAMETHASONE IN JAPANESE PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA
Ri, M.
Suzuki, K.
Chou, T.
Sugiura, I.
Takezako, N.
Sunami, K.
Ishida, T.
Izumi, T.
Ozaki, S.
Iida, S.
HAEMATOLOGICA, 2016, 101 : 787 - 788
[22] Lenalidomide plus dexamethasone treatment in Japanese patients with relapsed/refractory multiple myeloma
Shinsuke Iida
Takaaki Chou
Shinichiro Okamoto
Hirokazu Nagai
Kiyohiko Hatake
Hirokazu Murakami
Toshiyuki Takagi
Kazuyuki Shimizu
Henry Lau
Kenichi Takeshita
Masaaki Takatoku
Tomomitsu Hotta
International Journal of Hematology, 2010, 92 : 118 - 126
[23] A real-world efficacy and safety analysis of combined carfilzomib, lenalidomide, and dexamethasone (KRd) in relapsed/refractory multiple myeloma
Rocchi, Serena
Tacchetti, Paola
Pantani, Lucia
Mancuso, Katia
Rizzello, Ilaria
di Giovanni Bezzi, Chiara
Scalese, Marco
Dozza, Luca
Marzocchi, Giulia
Martello, Marina
Barila, Gregorio
Antonioli, Elisabetta
Staderini, Michela
Buda, Gabriele
Petrini, Mario
Cea, Michele
Quaresima, Micol
Furlan, Anna
Bonalumi, Angela
Cavo, Michele
Zamagni, Elena
HEMATOLOGICAL ONCOLOGY, 2021, 39 (01) : 41 - 50
[24] Carfilzomib, Lenalidomide, and Dexamethasone for Relapsed Multiple Myeloma
Stewart, A. Keith
Rajkumar, S. Vincent
Dimopoulos, Meletios A.
Masszi, Tamas
Spicka, Ivan
Oriol, Albert
Hajek, Roman
Rosinol, Laura
Siegel, David S.
Mihaylov, Georgi G.
Goranova-Marinova, Vesselina
Rajnics, Peter
Suvorov, Aleksandr
Niesvizky, Ruben
Jakubowiak, Andrzej J.
San-Miguel, Jesus F.
Ludwig, Heinz
Wang, Michael
Maisnar, Vladimr
Minarik, Jiri
Bensinger, William I.
Mateos, Maria-Victoria
Ben-Yehuda, Dina
Kukreti, Vishal
Zojwalla, Naseem
Tonda, Margaret E.
Yang, Xinqun
Xing, Biao
Moreau, Philippe
Palumbo, Antonio
NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (02) : 142 - 152
[25] Clinical Efficacy of Isatuximab Plus Carfilzomib and Dexamethasone in Relapsed/Refractory Multiple Myeloma Patients
De Novellis, Danilo
Derudas, Daniele
Vincelli, Donatella
Fontana, Raffaele
Della Pepa, Roberta
Palmieri, Salvatore
Accardi, Fabrizio
Rotondo, Francesco
Morelli, Emanuela
Gigliotta, Emilia
Roccotelli, Daniela
Marano, Luana
Barone, Maria Lucia
Cetani, Giusy
Esposito, Daniela
Lazzaro, Antonio
Delle Cave, Giuseppe
Serio, Bianca
Morini, Denise
Porrazzo, Marika
Urciuoli, Eleonora
Masucci, Chiara
Fanelli, Fulvia
Rizzo, Michela
Arcamone, Manuela
Trastulli, Fabio
Rocco, Stefano
Leone, Aldo
Bianco, Rosario
Salvatore, Flavia
Idato, Aurora
Sicari, Maria
Tosi, Patrizia
Rascato, Maria Gabriella
Di Perna, Maria
Falcone, Antonietta Pia
Morello, Lucia
Carlisi, Melania
Svanera, Gino
Annunziata, Mario
Frigeri, Ferdinando
Califano, Catello
Carella, Angelo Michele
Marcacci, Gianpaolo
Pane, Fabrizio
Risitano, Antonio Maria
Giudice, Valentina
Botta, Ciro
Selleri, Carmine
EUROPEAN JOURNAL OF HAEMATOLOGY, 2025, 114 (01) : 105 - 114
[26] Isatuximab plus carfilzomib-dexamethasone for relapsed multiple myeloma
Maruyama, Dai
Yamauchi, Nobuhiko
LANCET HAEMATOLOGY, 2024, 11 (10): : e710 - e711
[27] Daratumumab plus lenalidomide and dexamethasone versus lenalidomide and dexamethasone in relapsed or refractory multiple myeloma: updated analysis of POLLUX
Dimopoulos, Meletios A.
San-Miguel, Jesus
Belch, Andrew
White, Darrell
Benboubker, Lotfi
Cook, Gordon
Leiba, Merav
Morton, James
Ho, P. Joy
Kim, Kihyun
Takezako, Naoki
Moreau, Philippe
Kaufman, Jonathan L.
Sutherland, Heather J.
Lalancette, Marc
Magen, Hila
Iida, Shinsuke
Kim, Jin Seok
Prince, H. Miles
Cochrane, Tara
Oriol, Albert
Bahlis, Nizar J.
Chari, Ajai
O'Rourke, Lisa
Wu, Kaida
Schecter, Jordan M.
Casneuf, Tineke
Chiu, Christopher
Soong, David
Sasser, A. Kate
Khokhar, Nushmia Z.
Avet-Loiseau, Herve
Usmani, Saad Z.
HAEMATOLOGICA, 2018, 103 (12) : 2088 - 2096
[28] A matching-adjusted indirect comparison of isatuximab plus carfilzomib and dexamethasone versus daratumumab plus lenalidomide and dexamethasone for relapsed multiple myeloma
Richter, Joshua
Lin, Peggy
Garcia-Horton, Viviana
Guyot, Patricia
Singh, Erin
Zhou, Zheng-Yi
Sievert, Mark
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S156 - S157
[29] Venous thromboembolism in relapsed or refractory multiple myeloma patients treated with lenalidomide plus dexamethasone
Shin, Junghoon
Lee, Je-Jung
Kim, Kihyun
Min, Chang-Ki
Lee, Jeong-Ok
Suh, Cheolwon
Kim, Jin Seok
Lee, Yoo Jin
Yoon, Sung-Soo
Jo, Jae-Cheol
Lee, Ho Sup
Bang, Soo-Mee
Lee, Jeong-Ok
Bang, Soo-Mee
Lee, Je-Jung
Kim, Kihyun
Min, Chang-Ki
Suh, Cheolwon
Yoon, Dok Hyun
Kim, Jin Seok
Lee, Yoo Jin
Moon, Joon Ho
Yoon, Sung-Soo
Kim, Inho
Jo, Jae-Cheol
Lee, Ho Sup
Park, Seong Kyu
Shin, Ho-Jin
Kim, Min Kyoung
Mun, Yeung-Chul
Lee, Mark Hong
Park, Yong
Eom, Hyeon Seok
Kim, Hyo Jung
Im, Sung Nam
Kim, Sung-Hyun
Do, Young Rok
Lee, Won Sik
Cho, Su-Hee
Yi, Jun Ho
Lee, Jae Hoon
INTERNATIONAL JOURNAL OF HEMATOLOGY, 2019, 109 (01) : 79 - 90
[30] Venous thromboembolism in relapsed or refractory multiple myeloma patients treated with lenalidomide plus dexamethasone
Junghoon Shin
Je-Jung Lee
Kihyun Kim
Chang-Ki Min
Jeong-Ok Lee
Cheolwon Suh
Jin Seok Kim
Yoo Jin Lee
Sung-Soo Yoon
Jae-Cheol Jo
Ho Sup Lee
Soo-Mee Bang
International Journal of Hematology, 2019, 109 : 79 - 90

← 1 2 3 4 5 →